PROTEIN KINASES AND PHOSPHATASES AS DRUG TARGETS TO CURE HUMAN MALIGNANCIES
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Protein phosphorylation controls various aspects of cell proliferation, differentiation, metabolism, survival and motility. Protein kinases and phosphatases are involved in intracellular signal transduction pathways providing a dynamic and reversible regulation of many biological activities. One of the biggest challenges of modern medicine IS to identify promising therapeutic targets among these families of enzymes, which are involved in the development of various human cancers.
This review focuses on protein kinases and phosphatases as targets of small-molecule drugs. Some examples of breakthrough compounds are highlighted to illustrate achievements and challenges in the generation of smallmolecule inhibitors to cure human malignancies.
Downloads
Citations
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.